Skip to main content

BIOMEDICAL RESEARCH AND EDUCATION

EIN: 86-0622181Tucson, AZZIP: 85723
501(c)(3)

Mission

BREFSA'S RESEARCH MISSION IS TO PROMOTE BIOMEDICAL AND HEALTH SERVICE RESEARCH FOR THE BENEFIT OF VETERAN PATIENTS.

Financials

YearRevenueExpensesAssets
2023$696k$0$331k
2022$238k$0$383k

Compensation

2023

MARGARET BRADLEY
$0
$0
$0
$107,248
KENT BATTY
$0
$0
$0
$0
BARBARA BODE
$0
$0
$0
$0
JENNIFER GUTOWSKI
$0
$0
$0
$0
JOHN B KETTELLE IV
$0
$0
$0
$0
RAYMOND KACICH
$0
$0
$0
$0
SAIRAM PARTHASARATHY
$0
$0
$0
$0
SWATHY PUTHALAPATTU
$0
$0
$0
$0
DAWN C SCHWENKE
$0
$0
$0
$0
STEPHEN P THOMSON
$0
$0
$0
$0
EUGENE TROWERS
$0
$0
$0
$0
JASON WERTHEIM
$0
$0
$0
$0

2022

Bradley Margaret
$0
$0
$0
$101,909
Thomson Stephen P
$0
$0
$0
$0
Kettelle John B IV
$0
$0
$0
$0
Puthalapattu Swathy
$0
$0
$0
$0
Schwenke Dawn C
$0
$0
$0
$0
Batty Kent
$0
$0
$0
$0
Adams Midge
$0
$0
$0
$0
Kacich Raymond
$0
$0
$0
$0
Trowers Eugene
$0
$0
$0
$0
Wertheim Jason
$0
$0
$0
$0
Bode Barbara
$0
$0
$0
$0
Gutowski Jennifer
$0
$0
$0
$0
Parthasarathy Sairam
$0
$0
$0
$0

Explore related organizations

Similar Organizations

$754k revenue
Very similar revenue ($754k vs $696k)Same state (Arizona)Similar median compensation ($92k vs $105k)
$686k revenue
Very similar revenue ($686k vs $696k)Same state (Arizona)Similar median compensation ($109k vs $105k)
$659k revenue
Very similar revenue ($659k vs $696k)Same state (Arizona)Similar median compensation ($90k vs $105k)
Very similar revenue ($753k vs $696k)Same state (Arizona)Comparable compensation levels
$733k revenue
Very similar revenue ($733k vs $696k)Same state (Arizona)Similar size (28 vs 27 executives)
$646k revenue
Very similar revenue ($646k vs $696k)Same state (Arizona)
$646k revenue
Very similar revenue ($646k vs $696k)Same state (Arizona)
$723k revenue
Very similar revenue ($723k vs $696k)Same state (Arizona)
$670k revenue
Very similar revenue ($670k vs $696k)Same state (Arizona)
$663k revenue
Very similar revenue ($663k vs $696k)Same state (Arizona)

Learn more

Data from IRS Form 990 filings (2022-2023).